Live tape
Top 8, mentions 7d7,144NVDA1,224 mentions▲ +0.10GOOGL1,061 mentions▲ +0.04AVGO1,017 mentions▲ +0.05NKE1,002 mentions+0.02LULU948 mentions▲ +0.03TSLA823 mentions▲ +0.06META571 mentions▲ +0.06MSFT498 mentions▲ +0.07

Equity · Healthcare

CGEN

Compugen Ltd. · NasdaqCM

$2.58 +1.18% 1D Finazon · prior-day close · Sep 4, 2026
Price · Chart
Our own end-of-day closes 54 sessions
$3.0 $1.5 10 Jun 4 Sep

The line runs $2 on 10 June through $2.58 on 4 September, on a scale from $1.5 to $3.0. Days the market did not trade hold the previous close, flat.

The chart above plots the price of CGEN over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 54 sessions over that window: $2 on 10 June 2026 through $2.58 on 4 September 2026.

52-week range $1.33 – $3.11
Avg volume 52.1K

Finazon · prior-day close · as of Sep 8, 2026

Filings 3 sets

CGEN reported financials

SEC EDGAR XBRL

CGEN reported revenue of $72.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was $35.3M.

Figure Reported Period
Revenue $72.8M 31 Dec 2025 fiscal year
Net income $35.3M 31 Dec 2025 fiscal year
Diluted EPS $0.38 31 Dec 2025 fiscal year
Total assets $156.6M 31 Dec 2025 at period end
Total equity $102.7M 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

CGEN institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a CGEN position for the quarter ended 30 Jun 2026 — a combined $7.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) +15.0% shares 1,877,500 $4.0M
ARK Investment Management Trimmed −25.1% shares 786,536 $1.7M
Two Sigma Investments Held (±25%) −1.8% shares 512,419 $1.1M
Millennium Management Added +55.1% shares 262,032 $561K
Citadel Advisors Held (±25%) −7.9% shares 103,526 $222K
Marshall Wace Trimmed −92.0% shares 19,617 $42K
Point72 Asset Management New position 11,901 $25K

Source: SEC EDGAR 13F filings

CGEN fails-to-deliver

SEC CNS data

On 13 Aug 2026, 2,557 shares of CGEN failed to deliver (about $6K).

Settlement date Shares failed Notional % of shares out
13 Aug 2026 2,557 $6K 0.003%
11 Aug 2026 4,007 $9K 0.004%
05 Aug 2026 2,092 $5K 0.002%
04 Aug 2026 307 $731 <0.001%
31 Jul 2026 303 $709 <0.001%

Source: SEC fails-to-deliver (CNS) data